GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vilin Bio Med Ltd (NSE:VILINBIO) » Definitions » FCF Margin %

Vilin Bio Med (NSE:VILINBIO) FCF Margin % : -79.72% (As of Sep. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Vilin Bio Med FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Vilin Bio Med's Free Cash Flow for the six months ended in Sep. 2023 was ₹-60.95 Mil. Vilin Bio Med's Revenue for the six months ended in Sep. 2023 was ₹76.46 Mil. Therefore, Vilin Bio Med's FCF Margin % for the quarter that ended in Sep. 2023 was -79.72%.

As of today, Vilin Bio Med's current FCF Yield % is -23.00%.

The historical rank and industry rank for Vilin Bio Med's FCF Margin % or its related term are showing as below:

NSE:VILINBIO' s FCF Margin % Range Over the Past 10 Years
Min: -79.72   Med: -8.55   Max: 1.86
Current: -79.72


During the past 3 years, the highest FCF Margin % of Vilin Bio Med was 1.86%. The lowest was -79.72%. And the median was -8.55%.

NSE:VILINBIO's FCF Margin % is ranked worse than
88.8% of 1027 companies
in the Drug Manufacturers industry
Industry Median: -0.03 vs NSE:VILINBIO: -79.72


Vilin Bio Med FCF Margin % Historical Data

The historical data trend for Vilin Bio Med's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vilin Bio Med FCF Margin % Chart

Vilin Bio Med Annual Data
Trend Mar20 Mar21 Mar22
FCF Margin %
-8.80 -8.55 1.86

Vilin Bio Med Semi-Annual Data
Mar20 Mar21 Mar22 Sep22 Sep23
FCF Margin % - - - - -79.72

Competitive Comparison of Vilin Bio Med's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Vilin Bio Med's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vilin Bio Med's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vilin Bio Med's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Vilin Bio Med's FCF Margin % falls into.



Vilin Bio Med FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Vilin Bio Med's FCF Margin for the fiscal year that ended in Mar. 2022 is calculated as

FCF Margin=Free Cash Flow (A: Mar. 2022 )/Revenue (A: Mar. 2022 )
=2.086/112.149
=1.86 %

Vilin Bio Med's FCF Margin for the quarter that ended in Sep. 2023 is calculated as

FCF Margin=Free Cash Flow (Q: Sep. 2023 )/Revenue (Q: Sep. 2023 )
=-60.951/76.457
=-79.72 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vilin Bio Med FCF Margin % Related Terms

Thank you for viewing the detailed overview of Vilin Bio Med's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Vilin Bio Med (NSE:VILINBIO) Business Description

Traded in Other Exchanges
N/A
Address
Opposite Sub Registrar’s Office, Survey No.115/GF/J, Hanumanji Colony, Bowempally, Secunderabad, TG, IND, 500009
Vilin Bio Med Ltd is engaged in the domestic business of manufacturing Pharmaceuticals products. It is manufacturing pharmaceutical formulations such as Oral Liquids, Dry syrups, Sachets, External Preparations, Beta and Non-Beta Lactam tablets, and Capsules & Nutritional Food supplements.

Vilin Bio Med (NSE:VILINBIO) Headlines

No Headlines